Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay is a multiplex real-time PCR assay designed to detect N gene, RdRP gene and S gene for SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) A/B in a single tube. The assay is applied on Seegene’s integrated All-in-One automated platform which enables high-throughput testing.
- Dual whole process controls
- Short TAT (4 hours) from extraction to the final results
- Detection and differentiation of essential 7 viruses causing respiratory tract infections in a single reaction
- Providing the endogenous internal control in order to validate correct sampling for self-collected specimens
- PCR with high sensitivity and specificity
- Accurate test results allow to quick and proper treatment
The Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay for Detecting SARS-CoV-2 for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Atellica® IM SARS-CoV-2 IgG (sCOVG) assay for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Atellica® IM SARS-CoV-2 IgG (sCOVG) assay for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
